The hazard ratio for PFS events compared with placebo was @ ( @ % CI @-@ ; p = @ ) for rilotumumab @ mg/kg , @ ( @ % CI @-@ ; p = @ ) for rilotumumab @ mg/kg , and @ ( @ % CI @-@ ; p = @ ) for combined rilotumumab .